Market Overview

Benzinga's Top Initiations

Related AKBA
Akebia Shares Spike Sharply Higher As Traders Get Word Of Earlier $90 Price Target By Morgan Stanley
Morning Market Movers
Related AI
E*TRADE Financial Continues to Reduce Balance Sheet Risk - Analyst Blog
Medallion Financial In Focus: Stock Falls 6.3% - Tale Of The Tape

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (AI + AKBA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters